Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-20-019911

Director bought 850,000 shares at $19.00 ($16,150,000)

  • Director acquired 7,188,585 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

GOODMAN COREY S · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-21 Conversion : show line 1 in the form +3,100,020 3,969,789 I
2020-07-21 Purchase : show line 2 in the form +850,000 $19.00 $16,150,000 850,000 I
2020-07-21 Conversion : show line 3 in the form +3,941,949 5,268,325 I
2020-07-21 Conversion : show line 4 in the form +93,969 113,287 I
2020-07-21 Conversion : show line 5 in the form +52,647 54,083 I
Open-market purchases · 850,000 sh · avg $19.00 · $16,150,000

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2020-07-21 Conversion : show line 6 in the form Series A Convertible Stock −3,100,020 0 I
2020-07-21 Conversion : show line 7 in the form Series A Convertible Stock −2,398,588 0 I
2020-07-21 Conversion : show line 8 in the form Series B Convertible Stock −490,411 0 I
2020-07-21 Conversion : show line 9 in the form Series C Convertible Stock −1,052,950 0 I
2020-07-21 Conversion : show line 10 in the form Series A Convertible Stock −78,175 0 I
2020-07-21 Conversion : show line 11 in the form Series B Convertible Stock −15,794 0 I
2020-07-21 Conversion : show line 12 in the form Series C Convertible Stock −52,647 0 I
Loading xslF345X03/doc4.xml…